We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-3.07%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$46.8B
AUM Growth
+$933M
(+2%)
Cap. Flow
+$2.08B
Cap. Flow
% of AUM
4.45%
Top 10 Holdings %
Top 10 Hldgs %
8.13%
Holding
3,617
New
458
Increased
1,225
Reduced
1,321
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.31% |
| 4 | Industrials | 9.8% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Verrica Pharmaceuticals
VRCA
$87.3M
| $39.2K | ﹤0.01% |
8,867
-3,977
| -31% | -$25.7K |
|
3002
Greenland Technologies Holding
GTEC
$14.3M
| $38.5K | ﹤0.01% |
22,023
-96,578
| -81% | -$181K |
|
|
MRIN
3003
DELISTED
Marin Software
MRIN
| $37.3K | ﹤0.01% |
27,605
-5,418
| -16% | -$9.97K |
|
3004
E-Home Household Service Holdings
EJH
$4M
| $36.9K | ﹤0.01% |
+25
| New | +$23.7K |
|
3005
Beyond Meat
BYND
$277M
| $36.7K | ﹤0.01% |
12,018
-55,612
| -82% | -$205K |
|
3006
Cognition Therapeutics
CGTX
$96.7M
| $34.7K | ﹤0.01% |
82,544
+28,853
| +54% | +$17K |
|
|
HYFT
3007
MindWalk Holdings
HYFT
$61.6M
| $34.1K | ﹤0.01% |
+90,582
| New | +$40.8K |
|
3008
Biote Corp
BTMD
$44.9M
| $34K | ﹤0.01% |
10,204
-39,093
| -79% | -$186K |
|
3009
Newegg Commerce
NEGG
$359M
| $32.9K | ﹤0.01% |
+6,394
| New | +$51.4K |
|
3010
Gogoro
GGR
$51.2M
| $32.4K | ﹤0.01% |
6,000
-6,109
| -50% | -$51.6K |
|
|
ITRM
3011
DELISTED
Iterum Therapeutics
ITRM
| $31.1K | ﹤0.01% |
25,245
| – | – |
|
3012
Maison Solutions
MSS
$1.11M
| $30.9K | ﹤0.01% |
+599
| New | +$35.8K |
|
3013
Millennium Group International
MGIH
$17.2M
| $30.8K | ﹤0.01% |
+21,113
| New | +$34.6K |
|
3014
BuzzFeed
BZFD
$96.7M
| $29.7K | ﹤0.01% |
13,950
-132,428
| -90% | -$316K |
|
3015
Cibus
CBUS
$138M
| $29.1K | ﹤0.01% |
15,551
-9,023
| -37% | -$21.1K |
|
3016
ECARX Holdings
ECX
$432M
| $28.1K | ﹤0.01% |
+22,269
| New | +$47.6K |
|
|
ADAP
3017
DELISTED
Adaptimmune Therapeutics
ADAP
| $26.8K | ﹤0.01% |
135,947
+59,600
| +78% | +$30.9K |
|
|
PEV
3018
DELISTED
Phoenix Motor Inc. Common Stock
PEV
| $26.6K | ﹤0.01% |
76,424
+60,246
| +372% | +$21.6K |
|
3019
Skye Bioscience
SKYE
$18.3M
| $26.4K | ﹤0.01% |
+16,607
| New | +$45.3K |
|
3020
Cellectar Biosciences
CLRB
$20.5M
| $26.2K | ﹤0.01% |
2,770
+399
| +17% | +$3.61K |
|
3021
Outlook Therapeutics
OTLK
$191M
| $25.3K | ﹤0.01% |
20,719
+10,128
| +96% | +$17.8K |
|
|
LYRA
3022
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $24.4K | ﹤0.01% |
3,863
-337
| -8% | -$3.15K |
|
|
BTOC
3023
Armlogi Holding Corp
BTOC
$13.1M
| $24.1K | ﹤0.01% |
+24,102
| New | +$68.2K |
|
3024
Biomerica
BMRA
$4.98M
| $24K | ﹤0.01% |
+5,295
| New | +$26.2K |
|
3025
Seres Therapeutics
MCRB
$48.4M
| $22.6K | ﹤0.01% |
1,616
+395
| +32% | +$6.18K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Two Sigma Investments held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
Two Sigma Investments deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- Two Sigma Investments's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- Two Sigma Investments added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- Two Sigma Investments's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- Two Sigma Investments fully exited Coinbase in Q1 2025, selling an estimated $45M.
- Two Sigma Investments's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- Two Sigma Investments opened 458 new positions and closed 453 in Q1 2025.
- Two Sigma Investments's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.